drugset / Trial / NCT03826524
Epinephrine Dose: Optimal Versus Standard Evaluation Trial
Phase 4
Recruiting
3790 enrolled
Unity Health Toronto
Canadian Institutes of Health Research (CIHR) · collabPfizer · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of this randomized controlled trial is to evaluate the effectiveness of a low cumulative dose of epinephrine compared to a standard cumulative dose of epinephrine during resuscitation from ventricular fibrillation (VF) or ventricular tachycardia (VT) in adult out-of-hospital cardiac arrest (OHCA) patients.
Timeline
- Start
- 2023-05-24
- Primary completion
- 2027-12
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Epinephrine | Other / unclassified | 1 mg | Intravenous |